Department of Otolaryngology - Head and Neck Surgery, Western University, 3St. Joseph's Hospital, 268 Grosvenor Street, London, ON, N6A 4V2, Canada.
J Otolaryngol Head Neck Surg. 2021 Mar 17;50(1):18. doi: 10.1186/s40463-020-00480-z.
In the specialty of Otolaryngology - Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with industry. The purpose of this commentary is to review the nuances of each intranasal corticosteroid.
There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intranasal environment, and factors around patient adherence. Off-label use of budesonide irrigations is also discussed and cost information is presented in reference format for all available intranasal corticosteroids.
Although the efficacy of each intranasal corticosteroid has been shown to be similar, prescribing should be tailored based on bioavailability, intranasal environment, and factors that impact patient adherence such as dosing, cost and tolerability.
在耳鼻喉科-头颈外科领域,鼻内皮质类固醇是鼻腔内炎症过程的主要治疗方法。医生的处方模式往往基于以往的培训、个人经验和与行业的互动。本文的目的是回顾每种鼻内皮质类固醇的细微差别。
在加拿大,有九种鼻内皮质类固醇被批准使用。详细讨论了每种药物,包括其适应证、生物利用度、对鼻内环境的影响以及影响患者依从性的因素。还讨论了布地奈德冲洗的超适应证使用,并以参考格式提供了所有可用的鼻内皮质类固醇的成本信息。
虽然每种鼻内皮质类固醇的疗效已被证明相似,但应根据生物利用度、鼻内环境以及影响患者依从性的因素(如剂量、成本和耐受性)来调整处方。